Tenax Therapeutics awarded non-qualified stock options to purchase an aggregate of 160,000 shares of common stock to three newly hired non-executive employees in accounting, clinical operations, and CMC/product development roles. The options have an exercise price equal to the closing price on the grant date, with 25% vesting after one year and the remainder vesting monthly over 36 months. The awards were approved by the Board's Compensation Committee as material inducements to employment under Nasdaq Listing Rule 5635(c)(4) and were granted outside the company's stockholder-approved equity incentive plan.
Tenax Therapeutics IncInducement option awards for new hires, no direct business impact
Commercial Metals Company